Clinical-stage biotechnology firm Longeveron has named industry veteran Stephen Willard as its new chief executive officer, effective Feb. 11. Willard, 65, takes the helm from interim leader Than Powell as the company seeks to stabilize its executive leadership and advance its clinical pipeline.
Cathay General Bancorp announced a 12% increase to its quarterly cash dividend on Friday, raising the payout to 38 cents per share. The boost signals a strengthened capital return strategy for the financial holding company as it prepares for a March distribution to stockholders.
Enbridge CEO Gregory Ebel has signaled the company will not pursue Alberta's proposed crude oil pipeline to the British Columbia coast, citing prohibitive political and policy risks. Speaking during a Friday earnings call, Ebel emphasized that the infrastructure giant is prioritizing stable investments over projects in jurisdictions with a history of regulatory uncertainty.
Shares of raw material producers climbed as gold futures surged 2% to $5,022 an ounce, marking a resilient recovery for precious metals. The rally comes as market analysts weigh the potential impact of the Trump administration’s proposed mineral stockpiling program on global supply chains and long-term inflation.
Antero Resources Corporation has reached a settlement with the U.S. Department of Justice and West Virginia regulators to resolve alleged Clean Air Act violations across its regional energy operations. The agreement, announced Friday, requires the company to pay millions in penalties and commit to extensive infrastructure upgrades to curb emissions.
Artivion shares tumbled Friday after the cardiac and vascular surgery specialist reported fourth-quarter adjusted earnings and revenue that fell just short of analyst expectations, overshadowing the company’s successful swing to a net profit.
Electrovaya shares tumbled Friday afternoon after the Canadian lithium-ion battery manufacturer reported fiscal first-quarter revenue that trailed Wall Street estimates, overshadowing a surprise jump in profitability. Despite the top-line miss, the company maintained an optimistic full-year outlook based on expanding market demand.
Graco board member Brett Carter has resigned from his position effective Thursday, the industrial manufacturer disclosed in a regulatory filing. The departure, which the company confirmed was not the result of any internal disputes, marks an immediate exit for a director whose term was slated to run through 2027.
Bright Horizons Family Solutions shares plummeted on Friday, hitting a one-year low after the child care provider reported fourth-quarter earnings that significantly trailed analyst expectations. Despite a modest beat on revenue, the company’s net income fell to $21.7 million, sparking a 21% sell-off that extended a year-long decline for the stock.
Flowers Foods shares plummeted 11% on Friday after the packaged bakery giant issued a disappointing 2026 forecast and announced a comprehensive strategic review to combat persistent industry headwinds. Despite beating fourth-quarter earnings estimates, the maker of Dave’s Killer Bread warned that a shorter fiscal year and shifting consumer habits would likely stifle growth in the coming year.
Constellation Brands shares fell 4.5% on Friday after the beverage giant announced that Nicholas Fink, the current head of Fortune Brands Innovations, will succeed Bill Newlands as chief executive officer on April 13.
Chemed Corp. announced Friday that its board of directors has approved an additional $300 million for its share repurchase program, signaling a commitment to returning capital to investors. The company, which maintains a diverse portfolio ranging from hospice care to plumbing services, will integrate the new capacity into its existing repurchase framework.
Shares of biosensor developer Profusa plummeted on Friday as the company moved to raise capital through a 5.1 million unit equity offering, erasing gains from a high-profile clinical partnership announced just one day prior.
HA Sustainable Infrastructure Capital shares climbed 10% after the climate-focused investment firm reported fourth-quarter revenue that surpassed Wall Street estimates, extending its year-to-date rally to 26%.
10x Genomics shares jumped 11% on Friday morning after the biotechnology firm reported a narrower-than-expected fourth-quarter loss and revenue that cleared Wall Street estimates. The company’s ability to curb losses and maintain international growth momentum offset a slight decline in its American operations, fueling investor confidence.
NextEra Energy has increased its quarterly dividend by 10%, raising the payout to 62.32 cents per share as the clean-energy giant continues to signal financial strength. The Juno Beach, Florida-based company announced the hike following a period of robust market performance, with the new payout schedule set to begin in mid-March.
Norwegian Cruise Line Holdings (NCLH) shares tumbled more than 6% on Friday following the appointment of former Subway chief John Chidsey as its next CEO. The leadership transition comes as the company faces a dual challenge of a J.P. Morgan downgrade and a strategic pivot toward the premium family market, raising concerns over near-term execution risks.
Petroleum futures retreated late Friday morning as Nymex contracts headed for a weekly decline, driven by stagnant U.S. gasoline demand and reports that OPEC+ may soon increase global production.
Ultragenyx Pharmaceutical shares tumbled Friday after the biotech firm announced a sweeping reorganization, including a 10% workforce reduction, in a bid to reach profitability by 2027. The move follows a quarterly earnings report that showed revenue growth overshadowed by a wider-than-expected loss.
Shares of Alliance Entertainment tumbled Friday after the media and electronics distributor reported a 6.4% decline in second-quarter revenue, overshadowing an increase in bottom-line profits.
Bio-Rad Laboratories shares tumbled more than 10% on Friday after the life sciences firm reported fourth-quarter earnings that missed analyst expectations, citing a significant contraction in academic and biotech research funding.
Yelp shares plummeted nearly 10% on Friday after the business-review platform issued a 2026 revenue forecast that fell short of analyst expectations, overshadowing a narrow beat on its fourth-quarter results.
Galiano Gold shares jumped 14% on Friday following a fourth-quarter earnings report that significantly outpaced market expectations for both profit and revenue. The miner benefited from a massive scale-up in operations at its flagship Asanko mine in Ghana, setting a strong foundation for its 2024 production targets.
The Toronto Stock Exchange staged a broad recovery on Friday, buoyed by optimistic corporate guidance and reports that the U.S. administration may rescind tariffs on steel and aluminum. The S&P/TSX Composite Index climbed 1.6% to 32,984.81, reversing a volatile weekly trend as manufacturing and materials sectors led the advance.
Trump Media & Technology Group has filed with the Securities and Exchange Commission to launch two cryptocurrency exchange-traded funds, marking a significant expansion into digital asset management for the Truth Social operator.
Amkor Technology shares fell 6% on Friday after the company announced a secondary public offering of 10 million shares priced at $48.75 each. The sale, conducted by an investment vehicle for the founding Kim family, marks a significant insider liquidation even as the family maintains a near-majority stake.
Procore Technologies shares rallied 11% after the construction software firm reported fourth-quarter revenue that surpassed analyst expectations and issued an optimistic long-term outlook. The company posted revenue of $349 million, a 16% year-over-year increase, signaling robust demand for digital transformation within the building sector.
Federal regulators are investigating a Salmonella outbreak tied to Rosabella moringa powder capsules that has sickened seven people across seven states and resulted in three hospitalizations. The Food and Drug Administration and the CDC identified the supplement, distributed by Ambrosia Brands, as the common link among all interviewed patients.
Dexcom Inc. shares climbed Friday after the glucose-monitoring specialist reported fourth-quarter profit and revenue that surpassed analyst expectations, driven by sustained demand for its biosensing technology.
Forrester Research saw its stock price plummet 17% to a 52-week low following the release of fourth-quarter results that missed analyst expectations on both the top and bottom lines. The research and advisory firm reported a significant loss for the quarter, prompting an immediate restructuring effort to rein in costs and refocus on contract growth.
